Geneva Capital Management LLC Decreases Holdings in Shockwave Medical, Inc. (NASDAQ:SWAV)

Geneva Capital Management LLC decreased its holdings in Shockwave Medical, Inc. (NASDAQ:SWAV) by 13.4% in the fourth quarter, Holdings Channel.com reports. The firm owned 36,052 shares of the company’s stock after selling 5,578 shares during the period. Geneva Capital Management LLC’s holdings in Shockwave Medical were worth $6,870,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Covestor Ltd grew its stake in shares of Shockwave Medical by 484.9% during the third quarter. Covestor Ltd now owns 427 shares of the company’s stock valued at $85,000 after buying an additional 354 shares during the last quarter. International Assets Investment Management LLC grew its holdings in shares of Shockwave Medical by 18,122.1% in the fourth quarter. International Assets Investment Management LLC now owns 141,586 shares of the company’s stock worth $26,981,000 after purchasing an additional 140,809 shares during the last quarter. American Century Companies Inc. increased its stake in shares of Shockwave Medical by 109.0% in the third quarter. American Century Companies Inc. now owns 170,866 shares of the company’s stock worth $34,019,000 after buying an additional 89,094 shares during the period. AMI Asset Management Corp bought a new stake in Shockwave Medical during the 4th quarter valued at $4,092,000. Finally, Beck Bode LLC purchased a new stake in Shockwave Medical during the 4th quarter valued at $5,797,000. Institutional investors own 95.35% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on SWAV shares. Wells Fargo & Company raised their target price on Shockwave Medical from $200.00 to $210.00 and gave the stock an “equal weight” rating in a research note on Friday, February 16th. Needham & Company LLC reissued a “hold” rating on shares of Shockwave Medical in a research report on Friday, April 5th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $335.00 target price (up from $270.00) on shares of Shockwave Medical in a research report on Monday, April 8th. CL King reissued a “neutral” rating on shares of Shockwave Medical in a research note on Monday, April 8th. Finally, Wolfe Research reiterated a “peer perform” rating on shares of Shockwave Medical in a report on Friday, April 5th. Ten equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $309.11.

Insider Buying and Selling

In other Shockwave Medical news, CEO Douglas Evan Godshall sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 15th. The shares were sold at an average price of $231.56, for a total transaction of $2,315,600.00. Following the sale, the chief executive officer now owns 162,762 shares in the company, valued at approximately $37,689,168.72. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, CEO Douglas Evan Godshall sold 10,000 shares of the company’s stock in a transaction dated Thursday, February 15th. The stock was sold at an average price of $231.56, for a total value of $2,315,600.00. Following the completion of the transaction, the chief executive officer now owns 162,762 shares of the company’s stock, valued at $37,689,168.72. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Laura Francis sold 1,500 shares of Shockwave Medical stock in a transaction that occurred on Tuesday, March 26th. The shares were sold at an average price of $300.00, for a total value of $450,000.00. Following the sale, the director now directly owns 3,551 shares in the company, valued at approximately $1,065,300. The disclosure for this sale can be found here. In the last three months, insiders have sold 83,120 shares of company stock valued at $21,319,021. 3.40% of the stock is owned by company insiders.

Shockwave Medical Stock Up 0.0 %

Shares of NASDAQ:SWAV traded up $0.15 during trading on Friday, reaching $330.69. 210,275 shares of the stock traded hands, compared to its average volume of 915,867. Shockwave Medical, Inc. has a 52-week low of $157.00 and a 52-week high of $331.58. The stock has a 50-day moving average of $307.14 and a two-hundred day moving average of $241.29. The company has a debt-to-equity ratio of 1.09, a quick ratio of 10.73 and a current ratio of 11.76. The stock has a market cap of $12.42 billion, a P/E ratio of 77.27, a price-to-earnings-growth ratio of 2.46 and a beta of 0.88.

Shockwave Medical (NASDAQ:SWAV) last released its quarterly earnings results on Monday, May 6th. The company reported $1.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.99 by $0.45. Shockwave Medical had a return on equity of 23.97% and a net margin of 20.17%. The firm had revenue of $218.80 million for the quarter, compared to the consensus estimate of $207.69 million. During the same period last year, the business posted $1.03 EPS. The company’s revenue for the quarter was up 35.8% on a year-over-year basis. As a group, sell-side analysts expect that Shockwave Medical, Inc. will post 4.94 earnings per share for the current fiscal year.

Shockwave Medical Profile

Shockwave Medical, Inc, a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels.